Gamzu R, Yogev L, Botchan A, Amit A, Lessing J B, Lichtenberg D, Paz G, Yavetz H
Institute for the Study of Fertility, Tel Aviv Sourasky Medical Center, Israel.
Andrologia. 1997 Jan-Feb;29(1):17-21. doi: 10.1111/j.1439-0272.1997.tb03143.x.
The study was conducted to evaluate the diverse effect and clinical significance of TEST yolk buffer treatment on sperm samples of 128 infertile men. Sperm samples were incubated with TEST yolk buffer and control medium (Ham's F-10) at room temperature for 2 h. The hemizona indices (mean +/- SE) of the TEST yolk buffer and medium-treated sperm samples were 29 +/- 2.3% and 22 +/- 1.6%, respectively. Inspection of the individual response of each sperm sample to TEST yolk buffer revealed that 63 samples (49%) improved (double the interassay variation = 28%) their binding to zona pellucida, 36 (28%) remained unchanged, whereas the binding capacity of 29 samples (23%) decreased. Furthermore, TEST yolk buffer treatment of 24 samples (19%) resulted in an increased binding beyond the hemizona index threshold set up at 23%. This level was previously shown to be the cut-off point between fertile and infertile sperm samples. It was concluded that when applied to an unselected group of infertile men, TEST yolk buffer significantly increased sperm binding capacity to the zona pellucida. However, only 19% of the sperm samples showed improvement with clinical significance. The other sperm samples may have improved, remained unchanged or even deteriorated independently on basic sperm variables. Thus, the effect of TEST yolk buffer treatment on sperm binding should be tested prior to its clinical use to avoid possible damage to certain sperm samples.
本研究旨在评估TEST卵黄缓冲液处理对128名不育男性精子样本的不同影响及临床意义。将精子样本与TEST卵黄缓冲液和对照培养基(哈姆F-10)在室温下孵育2小时。TEST卵黄缓冲液处理组和培养基处理组精子样本的半透明带指数(平均值±标准误)分别为29±2.3%和22±1.6%。对每个精子样本对TEST卵黄缓冲液的个体反应进行检查发现,63个样本(49%)的透明带结合能力提高(超过批间变异的两倍=28%),36个样本(28%)保持不变,而29个样本(23%)的结合能力下降。此外,对24个样本(19%)进行TEST卵黄缓冲液处理后,其结合能力增加超过设定的半透明带指数阈值23%。此前已证明该水平是可育和不育精子样本的分界点。得出的结论是,当应用于未选择的不育男性群体时,TEST卵黄缓冲液显著提高了精子与透明带的结合能力。然而,只有19%的精子样本显示出具有临床意义的改善。其他精子样本可能在基本精子变量方面有所改善、保持不变甚至恶化。因此,在临床使用前应测试TEST卵黄缓冲液处理对精子结合的影响,以避免对某些精子样本造成可能的损害。